The Role of the Complement in Clear Cell Renal Carcinoma (ccRCC)—What Future Prospects Are There for Its Use in Clinical Practice?

The Role of the Complement in Clear Cell Renal Carcinoma (ccRCC)—What Future Prospects Are There for Its Use in Clinical Practice?

In recent years, the first-line available therapeutic options for metastatic renal cell carcinoma (mRCC) have radically changed with the introduction into clinical practice of new immune checkpoint inhibitor (ICI)-based combinations. Many efforts are focusing on identifying novel prognostic and pred...

Full description

Bibliographic Details
Main Authors: Martina Panebianco, Chiara Ciccarese, Alessandro Strusi, Viria Beccia, Carmine Carbone, Antonio Agostini, Geny Piro, Giampaolo Tortora, Roberto Iacovelli
Format: Article
Language:English
Published: MDPI AG 2024-01-01
Series:Cancers
Subjects:
mRCC
complement
classical pathway
“aggressive complement” tumor
biomarkers
immunotherapy
Online Access:https://www.mdpi.com/2072-6694/16/3/490

Internet

https://www.mdpi.com/2072-6694/16/3/490

Similar Items